NSE
LINCOLN
BSE
531633
ISIN
INE405C01035

LINCOLN PHARMA

Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals

₹520.85

+₹13.30 (+2.62%)

NSE close ·

LINCOLN PHARMA closed at ₹520.85 on 9 Nov 2026, up 2.62% on the day, and is down 0.29% over the past year.

52-week range32.4% below high
₹440.00₹770.00
TodayVolume 25,280
₹514.20₹528.65

Price history

Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹444.20 to ₹758.15.

Price returns, excl. dividends. 3Y, 5Y and Max are annualised.

Fundamentals

Market cap
₹1,043 Cr
Industry P/E
35.5
Dividend yield
0.35%

Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.

Quarterly results

LINCOLN PHARMA quarterly results
QuarterRevenueNet profitYoY profitEPS
Jun 2026₹202 Cr₹36.23 Cr—₹18.09

Armor risk check

LINCOLN PHARMA moves about 3× as much as the market

Volatility, past year

LINCOLN PHARMA43%
Nifty 50015%

Worst fall, past year

LINCOLN PHARMA−34%
Nifty 500−15%

Compared with the Nifty 500 over the past 12 months.

Check it against your portfolio in the app

FAQs

What is LINCOLN PHARMA's share price today?

LINCOLN PHARMA (NSE: LINCOLN) closed at ₹520.85 on 9 Nov 2026, up 2.62% from the previous close of ₹507.55. It traded between ₹514.20 and ₹528.65 that day.

What are LINCOLN PHARMA's 52-week high and low?

Over the last 52 weeks LINCOLN PHARMA traded between ₹440.00 and ₹770.00, adjusted for splits and bonuses.

What are LINCOLN PHARMA's NSE symbol, BSE code and ISIN?

LINCOLN PHARMA has NSE symbol LINCOLN, BSE code 531633, ISIN INE405C01035.

How has LINCOLN PHARMA performed over 1, 3 and 5 years?

LINCOLN PHARMA's share price return: 1Y −0.29%, 3Y −2.17% a year, 5Y +8.29% a year. Dividends are not included.

Does LINCOLN PHARMA pay a dividend?

Yes. LINCOLN PHARMA's latest dividend went ex on 11 Sep 2026: Final · ₹1.80 per share. Dividends over the past year come to a yield of 0.35% at the latest close.

What is LINCOLN PHARMA's market cap?

LINCOLN PHARMA's market cap is ₹1,043 Cr at the close on 9 Nov 2026.

Which sector is LINCOLN PHARMA in?

LINCOLN PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).

For information only. Not investment advice or a research report. Past performance does not guarantee future returns.

Full disclaimer

See how LINCOLN PHARMA fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app